Evidence for a Link of COVID-19-Associated Long-Term Neurologic Symptoms and Altered Brain Integrity?

References

1. 1.↵
   1. Thaweethai T,
   2. Jolley SE,
   3. Karlson EW, et al

   ; RECOVER Consortium. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA 2023;329:1934–46 doi:10.1001/jama.2023.8823 pmid:37278994

   CrossRefPubMed
2. 2.↵
   1. Adjaye-Gbewonyo D,
   2. Vahratian A,
   3. Perrine CG, et al

   . Long COVID in adults: United States, 2022. NCHS Data Brief 2023;1–8 pmid:37756137
3. 3.↵
   1. Augustin M,
   2. Schommers P,
   3. Stecher M, et al

   . Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 2021;6:100122 doi:10.1016/j.lanepe.2021.100122 pmid:34027514

   CrossRefPubMed
4. 4.↵
   1. Peter RS,
   2. Nieters A,
   3. Kräusslich HG, et al

   ; EPILOC Phase 1 Study Group. Post-acute sequelae of COVID-19 six to 12 months after infection: population-based study. BMJ 2022;379:e071050 doi:10.1136/bmj-2022-071050 pmid:36229057

   CrossRefPubMed
5. 5.↵
   1. Davis HE,
   2. McCorkell L,
   3. Vogel JM, et al

   . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023;21:133–46 doi:10.1038/s41579-022-00846-2 pmid:36639608

   CrossRefPubMed
6. 6.↵
   1. Kerksieck P,
   2. Ballouz T,
   3. Haile SR, et al

   . Post COVID-19 condition, work ability and occupational changes in a population-based cohort. Lancet Reg Health Eur 2023;31:100671 doi:10.1016/j.lanepe.2023.100671 pmid:37366496

   CrossRefPubMed
7. 7.↵
   1. Heine J,
   2. Schwichtenberg K,
   3. Hartung TJ, et al

   . Structural brain changes in patients with post-COVID fatigue: a prospective observational study. eClinicalMedicine 2023;58:101874 doi:10.1016/j.eclinm.2023.101874 pmid:36873426

   CrossRefPubMed
8. 8.↵
   1. Díez-Cirarda M,
   2. Yus M,
   3. Gómez-Ruiz N, et al

   . Multimodal neuroimaging in post-COVID syndrome and correlation with cognition. Brain 2023;146:2142–52 doi:10.1093/brain/awac384 pmid:36288544

   CrossRefPubMed
9. 9.↵
   1. Dacosta-Aguayo R,
   2. Puig J,
   3. Lamonja-Vicente N, et al

   ; Aliança ProHEpiC-19 Cognitiu (The APC Collaborative Group). Reduced cortical thickness correlates of cognitive dysfunction in post-COVID-19 condition: insights from a long-term follow-up. AJNR Am J Neuroradiol 2024;45:647–54 doi:10.3174/ajnr.A8167 pmid:38575319

   Abstract/FREE Full Text
10. 10.↵
    1. Paolini M,
    2. Palladini M,
    3. Mazza MG, et al

    . Brain correlates of subjective cognitive complaints in COVID-19 survivors: a multimodal magnetic resonance imaging study. Eur Neuropsychopharmacol 2023;68:1–10 doi:10.1016/j.euroneuro.2022.12.002 pmid:36640728

    CrossRefPubMed
11. 11.↵
    1. Hosp JA,
    2. Reisert M,
    3. Dressing A, et al

    . Cerebral microstructural alterations in post-COVID-condition are related to cognitive impairment, olfactory dysfunction and fatigue. Nat Commun 2024;15:4256 doi:10.1038/s41467-024-48651-0 pmid:38762609

    CrossRefPubMed
12. 12.↵
    1. O’Connor EE,
    2. Salerno-Goncalves R,
    3. Rednam N, et al

    . Macro and microstructural white matter differences in neurologic postacute sequelae of SARS-CoV-2 infection. AJNR Am J Neuroradiol 2024;45:1910–18 doi:10.3174/ajnr.A8481 pmid:39389778

    CrossRefPubMed
13. 13.↵
    1. Manivasagam S,
    2. Klein RS

    . Type III interferons: emerging roles in autoimmunity. Front Immunol 2021;12:764062 doi:10.3389/fimmu.2021.764062 pmid:34899712

    CrossRefPubMed
14. 14.↵
    1. Douaud G,
    2. Lee S,
    3. Alfaro-Almagro F, et al

    . SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 2022;604:697–707 doi:10.1038/s41586-022-04569-5 pmid:35255491

    CrossRefPubMed